机译:Predictive Genomic Biomarkers of Hormonal Therapy Versus Chemotherapy Benefit in Metastatic Castration-resistant Prostate Cancer
Foundation Medicine;
Vall d'Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital;
Department of Genitourinary Medical Oncology The University of Texas MD Anderson Cancer Center;
Drug development; Predictive biomarkers; Propensity; Prostate cancer; Real world;